In June 2024, Teva Pharmaceuticals Industries Limited (NYSE:TEVA) launched the first-ever authorized generic version of Victoza (liraglutide) injection in the U.S., marking a major milestone as ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to continue ...

Semaglutide injection products were first added to the FDA's drug shortage ... The petition argues that FDA-approved liraglutide-based products, Victoza, Saxenda, and Xultophy, meet patient ...

The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...

Many are losing up to 22.5 per cent of their weight in the first 18 months ... associated with Saxenda and Victoza, which contain liraglutide. Susan McGowan, 58, a Scottish nurse, died last year after ...

Victoza is competing against several other companies in the GLP-1 market, including AstraZeneca's Bydureon, which has a patient-friendly weekly injection ... has become the first FDA-approved ...

Freshly tightened regulations were introduced last month for those procuring weight loss injections online ... cent of their body weight within the first 18 months. The NHS is gearing up to ...

Novo Nordisk's semaglutide, which could be the first oral alternative to injectable ... currently headed by Novo's own $2 billion-a-year Victoza (liraglutide) brand which stands alongside other ...

In 2024 we launched 132 products across the business, including liraglutide injection in the US, the first approved ANDA for a GLP-1 referencing Victoza. I am excited that the team were able to ...